Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs population

Drug Testing and Analysis - Tập 10 Số 3 - Trang 539-547 - 2018
Sarah M. R. Wille1, Camille Richeval2,3, Florian Hakim2, Jean‐Michel Gaulier2,3, Vincent Di Fazio1, Luc Humbert2, Nele Samyn1, Delphine Allorge2,3
1Laboratory of Toxicology, National Institute of Criminalistics and Criminology, Brussels, Belgium
2CHU Lille, Unité fonctionnelle de toxicologie, Lille, France
3University Lille, EA 4483 – IMPECS – IMPact de l'Environnement Chimique sur la Santé humaine Lille France

Tóm tắt

Driving under the influence of drugs (DUID) is a worldwide problem. Several countries have adopted DUID legislations which prove their deterrent effect and impact on road safety. However, the use of new psychoactive substances (NPS) and prescription drugs is not known, as the applied roadside screening tests have not yet been adapted for these compounds. In this study, 558 blood samples obtained during roadside controls in Belgium (January to August 2015) after a positive Drugwipe 5S® test and 199 oral fluid (OF) samples obtained from negatively screened test pads were analyzed. The NPS positivity rate was 7% in blood, while it reached 11% in OF. NPS detected were: diphenidine, ketamine, 4‐fluoroamphetamine, 2‐amino‐indane, methoxetamine, α‐PVP, methiopropamine, a mix of 5‐MAPB/5‐EAPB, TH‐PVP, mephedrone, methedrone, 4‐methylethylcathinone, 5‐MeO‐DALT, 4‐Acetoxy‐DiPT, AB Fubinaca, FUB‐JWH018, JWH020, trifluoromethylphenylpiperazine, and ethylphenidate. Moreover, 17% of blood samples (and 5% of OF) contained an analgesic drug, 10% (0.5%) a benzodiazepine/hypnotic, 5% (2%) an antidepressant, 2% (3%) an antipsychotic, 2% an antiepileptic drug, and 1% methylphenidate. The presence of NPS in the young (and predominately male) DUID population is proven. Furthermore, a high level of poly‐drug use including combinations of NPS, licit, and drugs of abuse was observed. Further research concerning the development of on‐site NPS detection techniques should be established. Meanwhile, the effects of combined drug use on driving ability and the physical/psychological signs after NPS use should be performed to improve the on‐site DUID detection of NPS by police officers, so they can engage in blood sampling for a general unknown screening.

Từ khóa


Tài liệu tham khảo

European Commission DGMobility and Transport. Road Safety in the European Union European Commission 2015.http://ec.europa.eu/transport/road_safety/pdf/vademecum_2015.pdf[7 July 2017].

HouwingS HagenziekerM MathijssenR et al.DRUID‐Deliverable 2.2.3‐Part I; Prevalence of Alcohol and Other Psychoactive Substances in General Traffic. General Results SWOV Leidschendam 2011.

HelsT BerhoftIM LyckegaardA et al.DRUID‐Deliverable 2.3.5. Risk of Injury by Driving with Alcohol and Other Drugs Danish Transport Research Institute Kongens Lyngby 2012.

Parliament of Belgium.Wet tot wijziging van de wet betreffende de politie over het wegverkeer gecoördineerd op 16 maart 1968 (1) (Loi modifiant la loi relative à la police de la circulation routière coordonnée le 16 mars 1968) 16 maart (mars) 1999 Belgisch Staatsblad (Moniteur Belge) 30.03.1999.

Parliament of France.Loi n° 2003–87 Relative à la conduite sous l'influence de substances ou plantes classes comme stupéfiants 3 février2003.

10.1016/S0379-0738(01)00450-9

CederG.Drugged driving in Sweden – effects of new legislation concerning zero‐tolerance for narcotic drugs. In: H. Laurell ed.Proceedings of the 15thInternational Conference of Alcohol Drugs and Traffic Safety (ICADTS) Stockholm (Sweden) 2000.

Parliament of Victoria.Road safety (drug driving) act 2003 111/2003 2003.

2005, Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk assessment and control of new psychoactive substances, Official Journal L 127, 32

EMCDDA.New Psychoactive Substances in Europe – an update from the EU early warning system 2015 EMCCDAhttp://www.emcdda.europa.eu/publications/2015/new‐psychoactive‐substances. Accessed March 25 2015.

European Commission.Flash Eurobarometer 401: Young People and Drugs 2014 European Commission 2014 Young People and Drugs Flash Eurobarometer 401.http://ec.europa.eu/public_opinion/flash/fl_401_en.pdf/[7 July 2017].

10.1007/s00204-016-1812-x

10.1111/1556-4029.12550

10.1093/jat/bku067

10.1080/15389588.2015.1018990

10.1002/dta.1535

10.1111/1556-4029.12407

10.1016/j.aap.2013.09.009

10.1016/j.forsciint.2011.03.015

10.1080/15389588.2015.1036157

10.1007/s00414-015-1150-1

10.1093/anatox/35.8.577

10.1016/j.jchromb.2008.09.032

10.1097/FTD.0b013e31828e7e6b

10.1002/dta.1865

Kintz P, 2016, Detection of the designer benzodiazepine metizolam, in urine and preliminary data on its metabolism, Drug Test Anal

Wille SMR, 2017, Challenges concerning new psychoactive substance detection in oral fluid, Toxac.

10.1016/j.jchromb.2011.09.002

10.1373/clinchem.2012.184929

10.1002/dta.1688

10.1002/dta.2056

10.1002/bmc.3193

Richeval C, 2017, Dried saliva spots (DSS), tests immunochimiques de dépistage salivaire et produits stupéfiants, Toxic Analyt Clin., 29, 16

10.1016/j.drugalcdep.2016.01.024

10.1002/dta.1924

10.1007/s13318-016-0362-1

10.1016/j.drugalcdep.2012.12.011

10.1007/s00414-015-1280-5

10.1016/j.forsciint.2006.09.001

10.1016/S0006-3223(99)00097-9

10.1007/s11419-016-0309-x

Greene SL, 2013, Tryptamines. In: Novel Psychoactive Substances: Classification, Pharmacology and Toxicology

Thông tin
Thông tin xuất bản

Drug Testing and Analysis

Tập 10 Số 3

539-547

Thông tin tác giả